23 August, 2022

July’s release of U.S. Food and Drug Administration documents pertaining to the Emergency Use Authorization granted to the Pfizer-BioNTech COVID-19 vaccine included reports of a significant number of participants who withdrew from the trials — and the reasons for these withdrawals.